7 hot takes from HLTH

The latest stories trending on MedCity News.

Editor's Pick

Top Story 7 Hot Takes I Heard at HLTH AT HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference. Partnership Post Discover the Next-Gen Platform for Integrated Collaborative Care Presented by Careteam Beyond EHRs and digital front doors, reducing the gaps in patient care journeys. Learn More. Hurry Before They're Gone Last call to save $100 on INVEST Digital Health. Sale ends Sunday Night. Use Promo Code FRIDAY13 Register Now

Featured News

Enhancing Hiring at Healthcare Practices with Technology The last few years, both during and after the pandemic, have been turbulent times for healthcare providers and patients alike. For now, although it appears that healthcare staffing shortages will continue, providers are not without practical strategies for attracting and retaining talent. How Nemours Children's Is Working to Solve the 'Horrendous' Youth Mental Health Crisis If you could only do one thing to improve the health of children in the U.S., it would have to be in the behavioral health sphere, Nemours Children's Health CEO Lawrence Moss declared at HLTH. The state of youth mental health has reached a crisis point in the U.S., and Moss' health system is working hard to address this. Some of its efforts include embedding behavioral health into primary care and deploying behavioral health workers in schools. 4 Areas Within Digital Health That Will See Consolidation Next Year At the HLTH conference last week, MedCity News' editorial team interviewed 11 health leaders from a variety of organizations to get a sense of which areas within healthcare will see consolidation over the next 12 months. Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug Pfizer's new FDA-approved ulcerative colitis drug Velsipity comes from its $6.7 billion Arena Pharmaceuticals acquisition. The small molecule will compete against blockbuster Bristol Myers Squibb drug Zeposia, which addresses the same target.

Resources

Achieve Full HIPAA Compliance With the Help of This Checklist With our free HIPAA checklist, you can effortlessly pinpoint your compliance status and identify any remaining steps needed to achieve full HIPAA compliance. Get started today and easily find out where you stand and what else needs to be done! Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe